Arash Salardini, MD, describes how his research team is investigating the use of connectomics to determine biomarkers for predicting the risk of vascular dementia in patients with mild cognitive impairment.
Connectomics and the Search for Biomarkers of Vascular Cognitive Impairment
Dr. Salardini discloses grant support from NIH/NIA and the Taylor Foundation.